25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Achieve Life Sciences Inc
Buy, Hold or Sell?

Let's analyze Achieve Life Sciences Inc together

I guess you are interested in Achieve Life Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Achieve Life Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Achieve Life Sciences Inc

I send you an email if I find something interesting about Achieve Life Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Achieve Life Sciences Inc (30 sec.)










1.2. What can you expect buying and holding a share of Achieve Life Sciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.00
Expected worth in 1 year
$-0.12
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.12
Return On Investment
-2.7%

For what price can you sell your share?

Current Price per Share
$4.38
Expected price per share
$4.1 - $5.28
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Achieve Life Sciences Inc (5 min.)




Live pricePrice per Share (EOD)
$4.38
Intrinsic Value Per Share
$-3.31 - $9.26
Total Value Per Share
$-3.31 - $9.26

2.2. Growth of Achieve Life Sciences Inc (5 min.)




Is Achieve Life Sciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$31.3m$5.6m$24.7m81.5%

How much money is Achieve Life Sciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$8.2m-$8.9m$739.7k9.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Achieve Life Sciences Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#494 / 950

Most Revenue
#893 / 950

Most Profit
#518 / 950

Most Efficient
#261 / 950
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Achieve Life Sciences Inc?

Welcome investor! Achieve Life Sciences Inc's management wants to use your money to grow the business. In return you get a share of Achieve Life Sciences Inc.

First you should know what it really means to hold a share of Achieve Life Sciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Achieve Life Sciences Inc is $4.38. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Achieve Life Sciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Achieve Life Sciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.00. Based on the TTM, the Book Value Change Per Share is $-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Achieve Life Sciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.000.0%-0.15-3.4%-0.26-5.9%-0.20-4.6%-0.16-3.6%
Usd Book Value Change Per Share-1.23-28.1%-0.03-0.7%0.020.5%-0.01-0.3%-0.03-0.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.23-28.1%-0.03-0.7%0.020.5%-0.01-0.3%-0.03-0.6%
Usd Price Per Share4.74-4.53-4.69-5.36-3.51-
Price to Earnings Ratio-3,253.74--817.74--4.74--169.07--86.16-
Price-to-Total Gains Ratio-3.85--12.27--6.24--11.99--10.97-
Price to Book Ratio5,189.72-1,274.74-148.05-294.23-149.06-
Price-to-Total Gains Ratio-3.85--12.27--6.24--11.99--10.97-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.38
Number of shares228
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.03-0.01
Usd Total Gains Per Share-0.03-0.01
Gains per Quarter (228 shares)-6.65-2.69
Gains per Year (228 shares)-26.60-10.77
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-27-370-11-21
20-53-640-22-32
30-80-910-32-43
40-106-1180-43-54
50-133-1450-54-65
60-160-1720-65-76
70-186-1990-75-87
80-213-2260-86-98
90-239-2530-97-109
100-266-2800-108-120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%19.097.00.016.4%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%11.029.00.027.5%38.078.00.032.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0116.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%11.029.00.027.5%38.078.00.032.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Achieve Life Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.230-0.029-98%0.022-5745%-0.012-99%-0.028-98%
Book Value Per Share--0.0010.658-100%0.164-99%0.572-100%0.580-100%
Current Ratio--6.7793.862+76%4.609+47%6.901-2%5.308+28%
Debt To Asset Ratio--0.3450.515-33%0.800-57%0.425-19%0.351-2%
Debt To Equity Ratio--0.5270.369+43%13.891-96%4.141-87%2.280-77%
Dividend Per Share----0%-0%-0%-0%
Eps--0.000-0.149+40764%-0.259+71002%-0.201+55152%-0.158+43334%
Free Cash Flow Per Share--0.000-0.106+35079%-0.228+75309%-0.173+57103%-0.143+47247%
Free Cash Flow To Equity Per Share---0.0010.301-100%0.013-104%0.078-101%0.018-103%
Gross Profit Margin--1.0001.0050%1.0000%1.0010%1.0000%
Intrinsic Value_10Y_max--9.257--------
Intrinsic Value_10Y_min---3.314--------
Intrinsic Value_1Y_max---0.355--------
Intrinsic Value_1Y_min---0.685--------
Intrinsic Value_3Y_max---0.090--------
Intrinsic Value_3Y_min---1.765--------
Intrinsic Value_5Y_max--1.355--------
Intrinsic Value_5Y_min---2.515--------
Market Cap150414894.000-108163%162842937000.00040825477118.625+299%160888990.500+101114%8318006586.822+1858%4187631403.037+3789%
Net Profit Margin----0%-0%-0%-0.3280%
Operating Margin----0%-0%-0%-0.3160%
Operating Ratio----0%-0%-0%0.504-100%
Pb Ratio4795.561-8%5189.7171274.745+307%148.054+3405%294.233+1664%149.056+3382%
Pe Ratio-3006.616+8%-3253.735-817.743-75%-4.742-100%-169.072-95%-86.163-97%
Price Per Share4.380-8%4.7404.526+5%4.685+1%5.358-12%3.513+35%
Price To Free Cash Flow Ratio-3626.955+8%-3925.061-987.184-75%-5.690-100%-204.091-95%-103.587-97%
Price To Total Gains Ratio-3.560+8%-3.852-12.271+219%-6.237+62%-11.986+211%-10.971+185%
Quick Ratio--11.3585.802+96%4.395+158%7.032+62%5.649+101%
Return On Assets---0.261-0.192-27%-0.351+34%-0.243-7%-0.223-15%
Return On Equity---0.399-0.183-54%-6.381+1500%-2.115+430%-1.195+200%
Total Gains Per Share---1.230-0.029-98%0.022-5745%-0.012-99%-0.028-98%
Usd Book Value--31378000.00030417750.000+3%5620750.000+458%21200750.000+48%20707125.000+52%
Usd Book Value Change Per Share---1.230-0.029-98%0.022-5745%-0.012-99%-0.028-98%
Usd Book Value Per Share--0.0010.658-100%0.164-99%0.572-100%0.580-100%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.000-0.149+40764%-0.259+71002%-0.201+55152%-0.158+43334%
Usd Free Cash Flow---10372000.000-6237750.000-40%-7818250.000-25%-6448800.000-38%-5167925.900-50%
Usd Free Cash Flow Per Share--0.000-0.106+35079%-0.228+75309%-0.173+57103%-0.143+47247%
Usd Free Cash Flow To Equity Per Share---0.0010.301-100%0.013-104%0.078-101%0.018-103%
Usd Market Cap150414894.000-108163%162842937000.00040825477118.625+299%160888990.500+101114%8318006586.822+1858%4187631403.037+3789%
Usd Price Per Share4.380-8%4.7404.526+5%4.685+1%5.358-12%3.513+35%
Usd Profit---12512000.000-8235750.000-34%-8975500.000-28%-7613550.000-39%-5931175.000-53%
Usd Revenue----0%-0%-0%974975.000-100%
Usd Total Gains Per Share---1.230-0.029-98%0.022-5745%-0.012-99%-0.028-98%
 EOD+3 -5MRQTTM+14 -16YOY+17 -125Y+15 -1510Y+17 -15

3.3 Fundamental Score

Let's check the fundamental score of Achieve Life Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3,006.616
Price to Book Ratio (EOD)Between0-14,795.561
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than111.358
Current Ratio (MRQ)Greater than16.779
Debt to Asset Ratio (MRQ)Less than10.345
Debt to Equity Ratio (MRQ)Less than10.527
Return on Equity (MRQ)Greater than0.15-0.399
Return on Assets (MRQ)Greater than0.05-0.261
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Achieve Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.874
Ma 20Greater thanMa 504.522
Ma 50Greater thanMa 1004.713
Ma 100Greater thanMa 2004.638
OpenGreater thanClose4.460
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Fundamental data was last updated by Penke on 2024-11-14 09:01:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Achieve Life Sciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Achieve Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-32.8%+32.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--112.2%+112.2%
TTM--221.4%+221.4%
YOY--210.0%+210.0%
5Y--342.2%+342.2%
10Y-32.8%-464.5%+431.7%
4.3.1.2. Return on Assets

Shows how efficient Achieve Life Sciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • -26.1% Return on Assets means that Achieve Life Sciences Inc generated $-0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Achieve Life Sciences Inc:

  • The MRQ is -26.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -19.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.1%TTM-19.2%-6.9%
TTM-19.2%YOY-35.1%+15.9%
TTM-19.2%5Y-24.3%+5.1%
5Y-24.3%10Y-22.3%-2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.1%-11.3%-14.8%
TTM-19.2%-11.7%-7.5%
YOY-35.1%-11.3%-23.8%
5Y-24.3%-12.7%-11.6%
10Y-22.3%-14.1%-8.2%
4.3.1.3. Return on Equity

Shows how efficient Achieve Life Sciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • -39.9% Return on Equity means Achieve Life Sciences Inc generated $-0.40 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Achieve Life Sciences Inc:

  • The MRQ is -39.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-39.9%TTM-18.3%-21.6%
TTM-18.3%YOY-638.1%+619.9%
TTM-18.3%5Y-211.5%+193.2%
5Y-211.5%10Y-119.5%-92.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.9%-14.2%-25.7%
TTM-18.3%-15.9%-2.4%
YOY-638.1%-14.3%-623.8%
5Y-211.5%-18.5%-193.0%
10Y-119.5%-19.3%-100.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Achieve Life Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Achieve Life Sciences Inc is operating .

  • Measures how much profit Achieve Life Sciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Achieve Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-31.6%+31.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--222.9%+222.9%
TTM--310.7%+310.7%
YOY--223.5%+223.5%
5Y--387.1%+387.1%
10Y-31.6%-498.5%+466.9%
4.3.2.2. Operating Ratio

Measures how efficient Achieve Life Sciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.504-0.504
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.465-2.465
TTM-3.253-3.253
YOY-3.298-3.298
5Y-4.788-4.788
10Y0.5046.494-5.990
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Achieve Life Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Achieve Life Sciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.78 means the company has $6.78 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 6.779. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.862. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.779TTM3.862+2.917
TTM3.862YOY4.609-0.747
TTM3.8625Y6.901-3.039
5Y6.90110Y5.308+1.593
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.7793.637+3.142
TTM3.8623.890-0.028
YOY4.6094.666-0.057
5Y6.9015.953+0.948
10Y5.3086.277-0.969
4.4.3.2. Quick Ratio

Measures if Achieve Life Sciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 11.36 means the company can pay off $11.36 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 11.358. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.802. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.358TTM5.802+5.555
TTM5.802YOY4.395+1.407
TTM5.8025Y7.032-1.230
5Y7.03210Y5.649+1.383
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3583.086+8.272
TTM5.8023.451+2.351
YOY4.3954.456-0.061
5Y7.0325.931+1.101
10Y5.6496.436-0.787
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Achieve Life Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Achieve Life Sciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Achieve Life Sciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.35 means that Achieve Life Sciences Inc assets are financed with 34.5% credit (debt) and the remaining percentage (100% - 34.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 0.345. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.515. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.345TTM0.515-0.170
TTM0.515YOY0.800-0.285
TTM0.5155Y0.425+0.090
5Y0.42510Y0.351+0.075
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3450.350-0.005
TTM0.5150.344+0.171
YOY0.8000.310+0.490
5Y0.4250.365+0.060
10Y0.3510.382-0.031
4.5.4.2. Debt to Equity Ratio

Measures if Achieve Life Sciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 52.7% means that company has $0.53 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Achieve Life Sciences Inc:

  • The MRQ is 0.527. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.369. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.527TTM0.369+0.158
TTM0.369YOY13.891-13.523
TTM0.3695Y4.141-3.772
5Y4.14110Y2.280+1.861
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5270.394+0.133
TTM0.3690.432-0.063
YOY13.8910.380+13.511
5Y4.1410.451+3.690
10Y2.2800.490+1.790
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Achieve Life Sciences Inc generates.

  • Above 15 is considered overpriced but always compare Achieve Life Sciences Inc to the Biotechnology industry mean.
  • A PE ratio of -3,253.74 means the investor is paying $-3,253.74 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Achieve Life Sciences Inc:

  • The EOD is -3,006.616. Based on the earnings, the company is expensive. -2
  • The MRQ is -3,253.735. Based on the earnings, the company is expensive. -2
  • The TTM is -817.743. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3,006.616MRQ-3,253.735+247.119
MRQ-3,253.735TTM-817.743-2,435.992
TTM-817.743YOY-4.742-813.001
TTM-817.7435Y-169.072-648.672
5Y-169.07210Y-86.163-82.909
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3,006.616-2.303-3,004.313
MRQ-3,253.735-2.403-3,251.332
TTM-817.743-3.148-814.595
YOY-4.742-3.251-1.491
5Y-169.072-6.084-162.988
10Y-86.163-6.764-79.399
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Achieve Life Sciences Inc:

  • The EOD is -3,626.955. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3,925.061. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -987.184. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3,626.955MRQ-3,925.061+298.106
MRQ-3,925.061TTM-987.184-2,937.878
TTM-987.184YOY-5.690-981.493
TTM-987.1845Y-204.091-783.092
5Y-204.09110Y-103.587-100.504
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3,626.955-3.042-3,623.913
MRQ-3,925.061-3.234-3,921.827
TTM-987.184-3.719-983.465
YOY-5.690-4.557-1.133
5Y-204.091-8.332-195.759
10Y-103.587-9.276-94.311
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Achieve Life Sciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 5,189.72 means the investor is paying $5,189.72 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Achieve Life Sciences Inc:

  • The EOD is 4,795.561. Based on the equity, the company is expensive. -2
  • The MRQ is 5,189.717. Based on the equity, the company is expensive. -2
  • The TTM is 1,274.745. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4,795.561MRQ5,189.717-394.156
MRQ5,189.717TTM1,274.745+3,914.972
TTM1,274.745YOY148.054+1,126.691
TTM1,274.7455Y294.233+980.512
5Y294.23310Y149.056+145.177
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4,795.5611.943+4,793.618
MRQ5,189.7172.051+5,187.666
TTM1,274.7452.356+1,272.389
YOY148.0542.454+145.600
5Y294.2333.714+290.519
10Y149.0564.378+144.678
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Achieve Life Sciences Inc.

4.8.1. Institutions holding Achieve Life Sciences Inc

Institutions are holding 65.726% of the shares of Achieve Life Sciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Franklin Resources Inc17.62420.0066052374882861.4803
2024-06-30Propel Bio Management LLC7.14337.4774245309200
2024-06-30BlackRock Inc5.69730.0002195651019040793631.5901
2024-06-30Vanguard Group Inc4.38460.0001150573155729058.7585
2024-06-30Sofinnova Ventures4.04290.33911388372-129858-8.5532
2024-06-30Nantahala Capital Management, LLC3.80880.18021308000654000100
2024-06-30Geode Capital Management, LLC2.04020.0003700635493851238.8246
2024-06-30ADAR1 Capital Management LLC1.5790.4811542233-332767-38.0305
2024-06-30Alyeska Investment Group, L.P.1.37150.012747100000
2024-06-30Shay Capital LLC1.31040.291945000000
2024-06-30State Street Corp1.17670.0001404101348885631.8549
2024-06-30Long Focus Capital Management, LLC0.72250.044724809900
2024-06-30Simplify Asset Management Inc.0.63440.068721784500
2024-06-30Altium Capital Management, LP0.62990.4148216310-619160-74.1092
2024-06-30LPL Financial Corp0.54740.000418800055003.0137
2024-09-30Raymond James & Associates0.41740.0004143328-7121-4.7332
2024-06-30Northern Trust Corp0.36770.00011262732754127.8947
2024-06-30Bank of New York Mellon Corp0.29860.00011025551025550
2024-06-30Charles Schwab Investment Management Inc0.27920.000195886958860
2024-06-30Wells Fargo & Co0.2210.000175880707510.2827
Total 54.2979.318518646224+3196042+17.1%

4.9.2. Funds holding Achieve Life Sciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Franklin Biotechnology Discovery A6.3511.1179218102500
2024-09-30Franklin Biotechnology Discv A(acc)USD4.92170.5018169017000
2024-09-30Vanguard Total Stock Mkt Idx Inv2.9930.0003102782100
2024-10-31iShares Russell 2000 ETF2.42170.0057831633-1876-0.2251
2024-09-30Vanguard Institutional Extnd Mkt Idx Tr1.83410.002762986700
2024-08-31Fidelity Small Cap Index1.01330.0056347964-6677-1.8827
2024-09-30Simplify Propel Opportunities ETF0.63440.737921784500
2024-09-30Fidelity Extended Market Index0.55010.0021188927-11551-5.7617
2024-10-31iShares Russell 2000 Growth ETF0.53460.007218357800
2024-09-30Vanguard Russell 2000 ETF0.46040.0061581171928513.8909
2024-10-31State St Russell Sm Cap® Indx SL Cl I0.44490.007415280000
2024-10-31iShares Russell 2000 Value ETF0.35680.004612253300
2024-09-30Schwab Small Cap Index0.23670.0068128300
2024-09-30NT R2000 Index Fund - NL0.2360.005881057810570
2024-10-31iShares Micro-Cap ETF0.22810.04077832100
2024-09-30BlackRock Extended Equity Market K0.21620.002474261-32-0.0431
2024-09-30iShares Russell 2000 Small-Cap Idx Instl0.20.00626867000
2024-09-30NT R2000 Index Fund - DC - NL - 20.1890.005864906649060
2024-09-30Fidelity Total Market Index0.17770.0003610342499069.3319
2024-09-30Russell 2000 Index Non-Lendable Fund E0.16750.006257538-8894-13.3881
Total 24.16722.47268299350+161208+1.9%

5.3. Insider Transactions

Insiders are holding 9.724% of the shares of Achieve Life Sciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-05-30John BencichBUY50005.5
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets47,917
Total Liabilities16,539
Total Stockholder Equity31,378
 As reported
Total Liabilities 16,539
Total Stockholder Equity+ 31,378
Total Assets = 47,917

Assets

Total Assets47,917
Total Current Assets45,529
Long-term Assets2,388
Total Current Assets
Cash And Cash Equivalents 9,544
Short-term Investments 33,367
Other Current Assets 2,618
Total Current Assets  (as reported)45,529
Total Current Assets  (calculated)45,529
+/-0
Long-term Assets
Property Plant Equipment 20
Goodwill 1,034
Long-term Assets Other 1,334
Long-term Assets  (as reported)2,388
Long-term Assets  (calculated)2,388
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,716
Long-term Liabilities9,823
Total Stockholder Equity31,378
Total Current Liabilities
Short-term Debt 22
Accounts payable 1,011
Other Current Liabilities 5,683
Total Current Liabilities  (as reported)6,716
Total Current Liabilities  (calculated)6,716
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)9,823
Long-term Liabilities  (calculated)0
+/- 9,823
Total Stockholder Equity
Common Stock103
Retained Earnings -193,218
Accumulated Other Comprehensive Income 75
Other Stockholders Equity 224,418
Total Stockholder Equity (as reported)31,378
Total Stockholder Equity (calculated)31,378
+/-0
Other
Cash and Short Term Investments 42,911
Common Stock Shares Outstanding 34,355,050
Liabilities and Stockholders Equity 47,917
Net Debt 301
Net Working Capital 38,813
Short Long Term Debt Total 9,845



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-31
> Total Assets 
0
0
0
3,200
0
0
2,200
19,600
15,700
20,500
23,500
26,800
27,200
28,500
27,800
28,900
26,000
23,600
22,200
18,800
17,200
14,400
16,300
18,100
16,318
18,348
16,260
14,310
13,729
12,798
17,179
15,864
26,283
23,800
20,944
17,934
15,631
12,980
23,892
21,468
18,667
30,505
26,838
22,571
16,841
12,852
24,744
57,914
53,146
78,087
72,107
68,493
59,958
52,640
48,325
45,249
39,387
33,434
20,248
14,790
11,097
7,383
14,584
68,980
56,438
51,142
47,773
89,918
84,597
79,525
74,680
68,015
115,221
108,017
97,172
82,016
75,354
69,308
61,639
55,689
49,824
49,732
62,651
56,291
46,384
63,356
68,237
58,209
48,841
42,198
35,074
27,470
17,903
14,878
13,029
9,892
8,460
19,220
17,141
19,084
14,501
14,755
11,492
21,078
16,647
16,458
27,617
40,298
33,662
45,565
37,799
47,516
40,614
33,985
23,723
29,971
20,798
28,915
24,337
19,371
70,029
64,791
47,917
47,91764,79170,02919,37124,33728,91520,79829,97123,72333,98540,61447,51637,79945,56533,66240,29827,61716,45816,64721,07811,49214,75514,50119,08417,14119,2208,4609,89213,02914,87817,90327,47035,07442,19848,84158,20968,23763,35646,38456,29162,65149,73249,82455,68961,63969,30875,35482,01697,172108,017115,22168,01574,68079,52584,59789,91847,77351,14256,43868,98014,5847,38311,09714,79020,24833,43439,38745,24948,32552,64059,95868,49372,10778,08753,14657,91424,74412,85216,84122,57126,83830,50518,66721,46823,89212,98015,63117,93420,94423,80026,28315,86417,17912,79813,72914,31016,26018,34816,31818,10016,30014,40017,20018,80022,20023,60026,00028,90027,80028,50027,20026,80023,50020,50015,70019,6002,200003,200000
   > Total Current Assets 
0
0
0
1,900
0
0
500
18,400
14,600
19,200
22,400
25,500
26,000
27,100
26,200
27,200
24,200
21,900
20,600
17,400
16,000
13,300
15,300
17,200
15,567
17,698
15,695
13,808
13,288
12,426
16,797
15,467
25,451
22,505
19,540
16,624
14,167
11,493
22,325
19,862
17,122
28,978
25,263
21,039
15,423
11,563
23,585
56,716
52,033
76,889
70,787
66,846
58,409
50,874
46,533
35,232
29,610
23,949
19,682
14,249
10,539
6,683
13,991
68,399
55,849
50,560
47,194
89,318
83,916
78,809
73,973
67,326
114,551
104,888
95,817
80,179
74,917
67,587
59,707
53,867
48,149
47,853
61,315
55,262
45,506
62,747
67,597
57,570
47,985
41,380
34,296
27,199
17,452
14,464
8,626
5,908
4,746
15,572
13,519
15,537
10,531
10,802
7,639
17,384
12,902
12,656
24,112
36,975
30,439
42,431
34,733
44,594
37,692
31,148
20,957
24,837
18,224
26,478
21,897
16,982
67,709
62,519
45,529
45,52962,51967,70916,98221,89726,47818,22424,83720,95731,14837,69244,59434,73342,43130,43936,97524,11212,65612,90217,3847,63910,80210,53115,53713,51915,5724,7465,9088,62614,46417,45227,19934,29641,38047,98557,57067,59762,74745,50655,26261,31547,85348,14953,86759,70767,58774,91780,17995,817104,888114,55167,32673,97378,80983,91689,31847,19450,56055,84968,39913,9916,68310,53914,24919,68223,94929,61035,23246,53350,87458,40966,84670,78776,88952,03356,71623,58511,56315,42321,03925,26328,97817,12219,86222,32511,49314,16716,62419,54022,50525,45115,46716,79712,42613,28813,80815,69517,69815,56717,20015,30013,30016,00017,40020,60021,90024,20027,20026,20027,10026,00025,50022,40019,20014,60018,400500001,900000
       Cash And Cash Equivalents 
0
0
0
0
0
0
400
5,700
5,000
9,400
5,900
7,200
5,700
6,400
7,300
5,300
5,200
7,000
6,600
17,000
4,700
5,400
7,700
16,800
7,342
7,850
6,063
6,697
7,142
4,708
3,470
455
2,928
22,108
425
378
3,367
11,271
22,149
1,709
16,899
28,728
1,712
417
3,866
2,840
22,548
49,318
48,226
67,049
44,190
35,772
15,757
2,545
2,288
6,535
17,597
5,728
6,048
7,618
9,393
4,196
10,053
62,051
45,475
33,011
11,781
23,533
6,998
20,876
15,723
28,517
56,852
13,842
11,362
18,075
18,628
18,749
12,950
14,593
28,630
40,614
48,950
27,897
25,278
48,001
42,477
34,310
18,913
10,581
11,800
15,233
15,690
13,916
8,021
5,284
4,165
15,280
11,755
9,515
7,320
10,446
7,375
16,664
12,156
12,111
22,393
35,853
29,637
42,001
33,312
43,022
36,337
29,378
18,197
24,771
16,514
25,071
19,869
15,546
66,398
14,756
9,544
9,54414,75666,39815,54619,86925,07116,51424,77118,19729,37836,33743,02233,31242,00129,63735,85322,39312,11112,15616,6647,37510,4467,3209,51511,75515,2804,1655,2848,02113,91615,69015,23311,80010,58118,91334,31042,47748,00125,27827,89748,95040,61428,63014,59312,95018,74918,62818,07511,36213,84256,85228,51715,72320,8766,99823,53311,78133,01145,47562,05110,0534,1969,3937,6186,0485,72817,5976,5352,2882,54515,75735,77244,19067,04948,22649,31822,5482,8403,8664171,71228,72816,8991,70922,14911,2713,36737842522,1082,9284553,4704,7087,1426,6976,0637,8507,34216,8007,7005,4004,70017,0006,6007,0005,2005,3007,3006,4005,7007,2005,9009,4005,0005,700400000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
16,100
17,900
20,000
20,300
18,600
21,300
18,500
14,500
13,700
0
0
0
7,500
10,900
7,924
9,494
9,223
6,766
5,772
7,302
12,959
14,669
22,177
21,800
18,821
15,956
10,528
11,271
14,500
17,955
17,955
28,728
23,290
20,164
11,273
8,537
895
0
0
0
16,686
22,506
33,232
41,706
38,377
27,664
11,215
17,532
11,130
5,891
376
1,882
2,420
2,517
2,111
14,293
30,286
61,574
74,100
54,536
53,533
36,410
54,469
83,806
73,711
57,308
45,961
38,243
33,827
24,629
8,922
0
5,057
19,160
15,091
12,185
23,460
20,876
27,201
29,147
20,655
10,230
760
0
0
222
222
0
1,390
5,089
2,345
0
0
50
0
0
50
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,557
33,367
33,36746,55700000000000000500050002,3455,0891,39002222220076010,23020,65529,14727,20120,87623,46012,18515,09119,1605,05708,92224,62933,82738,24345,96157,30873,71183,80654,46936,41053,53354,53674,10061,57430,28614,2932,1112,5172,4201,8823765,89111,13017,53211,21527,66438,37741,70633,23222,50616,6860008958,53711,27320,16423,29028,72817,95517,95514,50011,27110,52815,95618,82121,80022,17714,66912,9597,3025,7726,7669,2239,4947,92410,9007,50000013,70014,50018,50021,30018,60020,30020,00017,90016,1000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,057
3,474
9,688
9,672
8,044
8,172
5,549
4,577
456
182
234
1,375
153
139
30
31
3,109
2,823
413
3,595
1,224
1,348
1,498
987
812
774
956
1,138
1,041
5,477
6,739
10,217
8,875
8,776
4,951
4,846
5,789
1,630
225
61
125
53
47
36
510
237
241
70
9
7
124
25
7
7
0
0
8
8
0
0
0
0
0
151
153
0
313
145
105
89
350
83
111
0
0
0
0001118335089105145313015315100000880077251247970241237510364753125612251,6305,7894,8464,9518,7768,87510,2176,7395,4771,0411,1389567748129871,4981,3481,2243,5954132,8233,10931301391531,3752341824564,5775,5498,1728,0449,6729,6883,4747,0570000000000000000000000005,0000000000000000000000000
       Other Current Assets 
0
0
0
1,900
0
0
100
12,700
9,600
9,800
16,500
18,300
20,300
20,700
18,900
21,900
19,000
14,900
14,000
400
11,300
7,900
100
400
302
354
408
346
374
416
368
343
346
397
294
290
271
222
176
199
223
250
261
459
284
186
142
342
333
152
239
524
1,249
1,073
1,291
577
616
455
546
587
631
575
734
722
5,440
2,843
1,532
2,987
1,470
1,899
3,730
1,587
2,456
6,284
9,606
3,755
4,537
3,542
2,713
5,770
1,821
2,288
2,462
2,165
499
304
1,599
1,987
233
307
158
954
765
307
535
393
574
168
349
926
866
356
264
670
746
545
1,669
1,122
802
430
1,270
1,419
1,355
1,457
2,615
2,454
1,621
1,308
1,895
1,325
1,311
1,206
2,618
2,6181,2061,3111,3251,8951,3081,6212,4542,6151,4571,3551,4191,2704308021,1221,6695457466702643568669263491685743935353077659541583072331,9871,5993044992,1652,4622,2881,8215,7702,7133,5424,5373,7559,6066,2842,4561,5873,7301,8991,4702,9871,5322,8435,4407227345756315875464556165771,2911,0731,2495242391523333421421862844592612502231991762222712902943973463433684163743464083543024001007,90011,30040014,00014,90019,00021,90018,90020,70020,30018,30016,5009,8009,60012,700100001,900000
   > Long-term Assets 
0
0
0
1,300
0
0
1,700
1,200
1,100
1,300
1,100
1,300
1,200
1,400
1,600
1,700
1,800
1,700
1,600
1,400
1,200
1,100
1,000
900
751
650
565
502
441
373
382
397
832
1,296
1,404
1,310
1,464
1,487
1,567
1,606
1,545
1,528
1,575
1,531
1,417
1,289
1,160
1,198
1,113
1,198
1,320
1,647
1,549
1,766
1,792
10,017
9,777
9,485
566
541
558
700
593
581
589
582
579
600
681
716
707
689
670
3,129
1,355
1,837
437
1,721
1,932
1,822
1,675
1,879
1,336
1,029
878
609
640
639
856
818
778
271
451
414
4,403
3,984
3,714
3,648
3,622
3,547
3,970
3,953
3,853
3,694
3,745
3,802
3,505
3,323
3,223
3,134
3,066
2,922
2,922
2,837
2,766
5,134
2,574
2,437
2,440
2,389
2,320
2,272
2,388
2,3882,2722,3202,3892,4402,4372,5745,1342,7662,8372,9222,9223,0663,1343,2233,3233,5053,8023,7453,6943,8533,9533,9703,5473,6223,6483,7143,9844,4034144512717788188566396406098781,0291,3361,8791,6751,8221,9321,7214371,8371,3553,1296706897077166816005795825895815937005585415669,4859,77710,0171,7921,7661,5491,6471,3201,1981,1131,1981,1601,2891,4171,5311,5751,5281,5451,6061,5671,4871,4641,3101,4041,2968323973823734415025656507519001,0001,1001,2001,4001,6001,7001,8001,7001,6001,4001,2001,3001,1001,3001,1001,2001,700001,300000
       Property Plant Equipment 
0
0
0
1,200
0
0
1,200
1,100
1,100
1,200
1,100
1,200
1,200
1,400
1,600
1,700
1,700
1,700
1,500
1,400
1,300
1,100
1,000
900
751
650
565
502
441
373
382
397
832
1,296
1,404
1,310
1,464
1,487
1,567
1,606
1,545
1,528
1,523
1,480
1,366
1,238
1,108
1,006
930
1,109
1,240
1,186
1,096
1,321
1,352
9,578
9,777
8,988
58
44
61
98
84
72
80
73
70
87
171
207
198
180
161
226
223
371
437
1,721
443
397
349
354
312
1,029
416
406
380
639
546
534
493
271
166
129
94
59
18
42
32
35
535
485
436
573
337
296
551
188
380
121
100
79
49
33
18
123
109
95
80
79
51
35
20
203551798095109123183349791001213801885512963375734364855353532421859941291662714935345466393804064161,0293123543493974431,721437371223226161180198207171877073807284986144588,9889,7779,5781,3521,3211,0961,1861,2401,1099301,0061,1081,2381,3661,4801,5231,5281,5451,6061,5671,4871,4641,3101,4041,2968323973823734415025656507519001,0001,1001,3001,4001,5001,7001,7001,7001,6001,4001,2001,2001,1001,2001,1001,1001,200001,200000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-5,894
-5,894
-5,894
-5,894
-5,894
0
0
0
-5,894
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,034
0
0
0
1
1
0
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,034
1,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0341,0340110001,0340000000000000000000-5,894000-5,894-5,894-5,894-5,894-5,89400000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
280
280
280
280
280
0
0
0
280
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,977
0
0
0
3
3
0
2,588
2,532
2,477
2,421
2,365
2,310
2,254
2,199
2,143
2,087
2,031
1,976
1,920
1,864
1,809
1,752
1,697
1,641
1,586
1,530
1,475
1,418
1,363
1,308
1,252
1,197
1,141
1,086
0
01,0861,1411,1971,2521,3081,3631,4181,4751,5301,5861,6411,6971,7521,8091,8641,9201,9762,0312,0872,1432,1992,2542,3102,3652,4212,4772,5322,5880330002,977000000000000000000028000028028028028028000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,175
1,111
1,075
1,274
773
273
272
13
38
37
38
12
13
0
13
13
4,309
3,925
185
151
191
168
147
0
240
237
343
0
358
237
239
227
235
183
253
240
239
0
0
0
0
0
0
0
0
00000000239240253183235227239237358034323724001471681911511853,9254,309131301312383738132722737731,2741,0751,1111,175000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
12,200
0
0
14,000
8,700
9,400
9,200
9,300
10,000
8,900
9,600
9,900
10,400
10,700
11,300
12,000
11,300
11,100
9,300
9,200
8,100
7,843
7,812
7,883
5,800
5,925
2,248
1,051
1,199
1,452
2,433
2,826
2,210
2,141
2,573
2,744
2,159
1,998
2,569
2,413
3,493
2,497
2,478
5,690
22,650
22,489
23,081
22,927
25,451
19,627
17,325
18,739
13,345
11,286
8,917
4,768
4,083
2,702
3,445
3,576
46,021
36,169
30,243
33,470
45,793
43,099
44,327
34,655
37,125
37,094
33,302
27,411
15,809
15,089
16,623
18,096
18,478
20,220
23,267
23,800
22,232
16,365
35,165
29,465
20,769
14,625
13,949
10,655
8,504
2,012
1,775
2,347
2,013
2,318
2,778
2,977
3,282
4,312
3,251
3,351
3,028
1,662
1,920
1,942
3,012
3,574
4,711
3,099
19,474
19,181
20,819
22,679
21,668
20,355
19,216
20,299
20,819
20,573
22,506
16,539
16,53922,50620,57320,81920,29919,21620,35521,66822,67920,81919,18119,4743,0994,7113,5743,0121,9421,9201,6623,0283,3513,2514,3123,2822,9772,7782,3182,0132,3471,7752,0128,50410,65513,94914,62520,76929,46535,16516,36522,23223,80023,26720,22018,47818,09616,62315,08915,80927,41133,30237,09437,12534,65544,32743,09945,79333,47030,24336,16946,0213,5763,4452,7024,0834,7688,91711,28613,34518,73917,32519,62725,45122,92723,08122,48922,6505,6902,4782,4973,4932,4132,5691,9982,1592,7442,5732,1412,2102,8262,4331,4521,1991,0512,2485,9255,8007,8837,8127,8438,1009,2009,30011,10011,30012,00011,30010,70010,4009,9009,6008,90010,0009,3009,2009,4008,70014,0000012,200000
   > Total Current Liabilities 
0
0
0
8,800
0
0
10,600
8,200
9,000
8,700
9,000
9,600
8,700
9,500
9,800
9,500
9,200
9,400
9,900
9,300
9,000
9,300
9,200
8,000
7,843
7,812
7,883
5,800
5,925
2,248
1,051
1,199
1,346
2,159
2,518
1,938
1,906
2,375
2,584
2,038
1,917
2,514
2,364
3,255
2,281
2,286
5,520
11,242
12,491
14,492
15,924
19,910
15,473
14,557
18,739
6,369
4,433
2,158
3,605
2,884
1,483
2,190
2,308
25,781
18,131
12,945
13,467
27,476
25,612
27,855
19,119
30,786
30,952
27,362
21,673
11,556
11,001
12,716
14,368
14,934
16,900
20,171
20,927
22,218
16,237
35,035
29,348
20,664
14,533
13,865
10,588
8,455
1,980
1,753
2,331
2,013
2,318
2,760
2,962
3,270
3,999
2,988
3,139
2,869
1,544
1,810
1,848
2,935
3,515
4,670
3,076
4,550
4,010
5,359
6,916
5,528
20,301
3,447
4,082
20,813
20,573
13,702
6,716
6,71613,70220,57320,8134,0823,44720,3015,5286,9165,3594,0104,5503,0764,6703,5152,9351,8481,8101,5442,8693,1392,9883,9993,2702,9622,7602,3182,0132,3311,7531,9808,45510,58813,86514,53320,66429,34835,03516,23722,21820,92720,17116,90014,93414,36812,71611,00111,55621,67327,36230,95230,78619,11927,85525,61227,47613,46712,94518,13125,7812,3082,1901,4832,8843,6052,1584,4336,36918,73914,55715,47319,91015,92414,49212,49111,2425,5202,2862,2813,2552,3642,5141,9172,0382,5842,3751,9061,9382,5182,1591,3461,1991,0512,2485,9255,8007,8837,8127,8438,0009,2009,3009,0009,3009,9009,4009,2009,5009,8009,5008,7009,6009,0008,7009,0008,20010,600008,800000
       Short-term Debt 
0
0
0
3,200
0
0
4,100
5,200
5,000
5,200
5,200
5,200
5,200
5,200
5,200
5,100
5,100
5,100
5,100
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
0
19
75
134
138
141
144
148
151
155
143
111
78
45
26
27
27
28
29
22
15
8,047
0
0
0
0
903
905
632
361
717
457
1,328
1,307
1,278
1,344
1,314
1,305
1,384
1,406
1,417
1,429
1,440
1,451
1,084
1,088
1,089
1,090
1,092
1,097
1,106
1,114
236
52
54
53
52
51
57
57
57
55
46
31
27
0
11
11
11
186
192
198
203
196
165
129
92
67
68
69
69
59
41
23
58
16,429
60
61
16,725
17,194
8,841
22
228,84117,19416,725616016,42958234159696968679212916519620319819218611111102731465557575751525354522361,1141,1061,0971,0921,0901,0891,0881,0841,4511,4401,4291,4171,4061,3841,3051,3141,3441,2781,3071,32845771736163290590300008,047152229282727264578111143155151148144141138134751905,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,1005,1005,1005,1005,2005,2005,2005,2005,2005,2005,0005,2004,100003,200000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,486
0
0
0
683
0
0
0
829
850
46
31
27
0
0
0
0
170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,071
16,371
0
0
16,662
17,141
8,804
0
08,80417,14116,6620016,37116,0710000000000000017000002731468508290006830003,48600000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
900
0
0
2,600
1,400
1,800
1,100
2,300
2,200
2,100
2,400
3,000
2,600
2,300
2,600
3,200
3,000
2,900
3,500
4,000
2,800
2,622
2,663
2,766
800
925
0
0
1,199
1,327
2,084
2,384
1,801
1,765
2,231
2,436
1,887
1,762
2,371
2,253
3,177
2,236
2,259
5,493
5,668
368
1,577
1,259
2,372
1,847
1,912
2,923
1,462
1,429
152
2,700
0
0
0
0
0
0
0
0
893
1,166
1,643
1,465
3,217
2,877
2,883
5,718
7,050
7,925
130
39
139
923
1,341
1,562
72
988
302
1,779
1,343
592
559
1,043
2,121
359
233
495
213
420
251
458
144
694
707
574
859
184
523
326
332
585
575
815
841
418
656
412
1,660
1,063
361
638
618
373
550
1,011
1,0115503736186383611,0631,6604126564188418155755853323265231848595747076941444582514202134952333592,1211,0435595921,3431,779302988721,5621,341923139391307,9257,0505,7182,8832,8773,2171,4651,6431,166893000000002,7001521,4291,4622,9231,9121,8472,3721,2591,5773685,6685,4932,2592,2363,1772,2532,3711,7621,8872,4362,2311,7651,8012,3842,0841,3271,199009258002,7662,6632,6222,8004,0003,5002,9003,0003,2002,6002,3002,6003,0002,4002,1002,2002,3001,1001,8001,4002,60000900000
       Other Current Liabilities 
0
0
0
4,700
0
0
3,900
1,600
2,200
2,400
1,500
2,200
1,400
1,900
1,600
1,800
1,800
1,700
1,600
1,300
1,100
800
200
200
221
149
117
0
-25
2,248
1,051
1
-46
41
-18
0
1,765
2,231
0
0
0
2,371
2,253
3,176,709
2,236
2,259
5,493
0
6,549
7,341
9,097
11,978
32
7,099
8,889
4,906
3,004
903
3,605
2,252
1,122
1,473
1,851
14,453
6,824
1,667
2,123
15,269
13,141
14,828
9,119
7,881
13,617
11,990
12,528
10,472
9,913
1,087
548
214
935
3,494
3,975
6,252
3,787
16,901
16,475
14,229
11,791
2,221
350
232
180
114
3
1,773
1,898
11
11
3,115
170
2,089
2,367
1,807
1,164
1,122
1,393
2,511
2,863
4,027
2,192
3,640
3,533
4,662
6,481
3,810
2,809
3,026
3,383
3,470
3,006
4,311
5,683
5,6834,3113,0063,4703,3833,0262,8093,8106,4814,6623,5333,6402,1924,0272,8632,5111,3931,1221,1641,8072,3672,0891703,11511111,8981,77331141802323502,22111,79114,22916,47516,9013,7876,2523,9753,4949352145481,0879,91310,47212,52811,99013,6177,8819,11914,82813,14115,2692,1231,6676,82414,4531,8511,4731,1222,2523,6059033,0044,9068,8897,0993211,9789,0977,3416,54905,4932,2592,2363,176,7092,2532,3710002,2311,7650-1841-4611,0512,248-2501171492212002008001,1001,3001,6001,7001,8001,8001,6001,9001,4002,2001,5002,4002,2001,6003,900004,700000
   > Long-term Liabilities 
0
0
0
3,400
0
0
3,400
500
400
500
300
400
200
100
100
900
1,500
1,900
2,100
2,000
2,100
8,500
9,000
100
7,600
7,700
7,766
5,800
5,925
0
0
1,199
107
274
308
272
235
198
160
121
81
55
49
238
216
193
170
11,408
9,999
8,589
7,002
5,541
4,154
2,768
9,850
6,976
6,852
6,759
1,163
1,199
1,219
1,255
1,268
20,240
18,038
17,298
20,003
18,317
17,487
16,472
15,536
6,339
6,142
5,940
5,738
4,253
4,088
3,907
3,728
3,544
3,320
3,096
2,873
14
128
130
117
105
92
84
67
49
32
22
16
240
420
18
15
12
313
263
212
159
118
110
94
77
59
41
23
14,924
15,171
15,460
15,763
16,140
54
15,769
16,217
6
0
8,804
9,823
9,8238,8040616,21715,7695416,14015,76315,46015,17114,924234159779411011815921226331312151842024016223249678492105117130128142,8733,0963,3203,5443,7283,9074,0884,2535,7385,9406,1426,33915,53616,47217,48718,31720,00317,29818,03820,2401,2681,2551,2191,1991,1636,7596,8526,9769,8502,7684,1545,5417,0028,5899,99911,4081701932162384955811211601982352723082741071,199005,9255,8007,7667,7007,6001009,0008,5002,1002,0002,1001,9001,5009001001002004003005004005003,400003,400000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,606
6,500
6,339
6,142
5,940
5,738
4,253
4,088
3,907
3,728
3,544
3,320
3,096
2,873
14
128
130
117
105
92
84
67
49
32
22
16
0
0
18
15
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001215180016223249678492105117130128142,8733,0963,3203,5443,7283,9074,0884,2535,7385,9406,1426,3396,5006,606000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
627
0
0
0
124
0
0
16
0
0
18
15
12
24
20
212
159
0
110
94
2
59
0
23
4
0
0
0
0
0
0
0
0
0
0
0
0000000000042305929411001592122024121518001600124000627000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,866
9,036
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000009,0369,866000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
-9,000
0
0
-11,800
10,900
6,300
11,300
14,200
16,800
18,300
18,900
17,900
18,500
15,300
12,300
10,200
7,500
6,100
5,100
7,100
10,000
8,475
10,536
8,377
8,509
7,804
10,551
16,128
14,665
24,831
21,368
18,118
15,724
13,490
10,406
21,149
19,310
16,669
27,936
24,425
19,077
14,344
10,373
19,054
35,264
30,657
55,006
49,181
43,042
40,331
35,315
29,586
31,904
28,101
24,516
15,480
10,707
8,395
3,938
11,008
22,959
20,269
20,899
14,303
44,125
41,498
35,198
40,025
30,890
78,127
74,715
69,761
66,207
60,265
52,685
43,543
37,211
29,604
26,465
38,851
34,059
30,019
28,191
38,772
37,440
34,216
28,249
24,419
18,966
15,891
13,103
10,682
7,879
6,142
16,442
14,164
15,802
10,189
11,504
8,141
18,050
14,985
14,538
25,675
37,286
30,088
40,854
34,700
28,042
21,433
13,166
1,044
8,303
443
9,699
4,038
-1,448
49,456
42,285
31,378
31,37842,28549,456-1,4484,0389,6994438,3031,04413,16621,43328,04234,70040,85430,08837,28625,67514,53814,98518,0508,14111,50410,18915,80214,16416,4426,1427,87910,68213,10315,89118,96624,41928,24934,21637,44038,77228,19130,01934,05938,85126,46529,60437,21143,54352,68560,26566,20769,76174,71578,12730,89040,02535,19841,49844,12514,30320,89920,26922,95911,0083,9388,39510,70715,48024,51628,10131,90429,58635,31540,33143,04249,18155,00630,65735,26419,05410,37314,34419,07724,42527,93616,66919,31021,14910,40613,49015,72418,11821,36824,83114,66516,12810,5517,8048,5098,37710,5368,47510,0007,1005,1006,1007,50010,20012,30015,30018,50017,90018,90018,30016,80014,20011,3006,30010,900-11,80000-9,000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
34,300
34,300
34,300
34,500
34,700
34,900
34,900
35,000
35,000
35,000
35,000
37,100
37,100
37,100
37,714
37,720
37,727
38,077
38,097
42,590
42,627
43,302
55,953
55,986
55,990
56,011
56,062
56,073
69,319
70,085
71,019
86,088
86,177
86,202
86,234
86,344
103,917
123,444
124,144
153,425
153,896
154,781
155,304
156,264
156,323
156,705
157,015
157,248
6
6
6
6
6
6
6
6
6
10
10
10
10
10
15
14
15
15
15
15
15
15
15
15
21
22
22
24
30
29
30
29
30
29
30
30
11
12
13
15
16
18
18
19
19
41
43
51
74
76
76
79
79
79
79
79
79
87
87
90
90
90
103
103
103
1031031039090908787797979797979767674514341191918181615131211303029302930293024222221151515151515151514151010101010666666666157,248157,015156,705156,323156,264155,304154,781153,896153,425124,144123,444103,91786,34486,23486,20286,17786,08871,01970,08569,31956,07356,06256,01155,99055,98655,95343,30242,62742,59038,09738,07737,72737,72037,71437,10037,10037,10035,00035,00035,00035,00034,90034,90034,70034,50034,30034,30034,3000000000000
   Retained Earnings Total Equity000000-144,928-135,93600000-79,744-68,433-60,434-55,710-51,946-49,024-45,704-42,510-38,837-31,288-25,381-21,744-18,504-15,716-12,694-8,915-203,230-200,230-196,942-191,097-187,407-180,518-176,811-175,087-170,537-164,527-159,958-154,276-149,340-142,325-133,689-127,011-116,957-108,537-101,840-97,737-91,817-87,602-80,742-71,173-75,644000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-400
0
0
-700
-800
-900
-1,000
-200
0
0
0
0
0
0
0
0
0
0
0
0
0
-18
-18
-18
1
-341
-340
46
40
-32
16
32
26
15
7
3
4
8
-32
-20
-35
-24
-14
2
7
10
14
11
0
-9
-22
-2
1
3
-8
2,608
2,640
2,639
2,639
2,642
2,640
2,642
2,640
2,640
2,605
2,662
2,608
2,528
2,636
2,636
2,617
2,655
2,637
2,631
2,616
2,640
2,643
2,642
2,641
2,637
2,622
2,635
2,637
2,642
2,632
2,646
2,650
2,643
2,640
2,641
2,641
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
-7
75
75-74444444444444444444444555552,6412,6412,6402,6432,6502,6462,6322,6422,6372,6352,6222,6372,6412,6422,6432,6402,6162,6312,6372,6552,6172,6362,6362,5282,6082,6622,6052,6402,6402,6422,6402,6422,6392,6392,6402,608-831-2-22-9011141072-14-24-35-20-32843715263216-324046-340-3411-18-18-180000000000000-200-1,000-900-800-70000-400000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
108,224
108,660
108,986
163,078
163,901
164,828
165,395
166,156
167,011
167,899
168,242
169,272
173,149
190,469
191,373
191,889
196,067
211,187
211,590
212,058
212,977
212,843
213,239
213,450
213,662
19,581
20,556
21,840
34,926
35,887
41,161
41,455
50,318
50,628
63,709
63,962
66,429
81,307
97,640
98,441
120,515
0
0
0
0
0
144,148
145,280
0
0
0
0
0
0
000000145,280144,14800000120,51598,44197,64081,30766,42963,96263,70950,62850,31841,45541,16135,88734,92621,84020,55619,581213,662213,450213,239212,843212,977212,058211,590211,187196,067191,889191,373190,469173,149169,272168,242167,899167,011166,156165,395164,828163,901163,078108,986108,660108,224000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
500
0
0
900
30,700
31,000
35,100
100
-100
0
0
-100
-100
0
0
-100
0
0
0
100
0
-8
54
-5
-350
3,204
3,251
-19
3,765
3,731
3,868
-14
0
56,062
0
0
0
0
0
0
86,167,537
3
0
103,917
7,499
0
0
11
0
0
0
0
156,704,899
157,015
0
55,920
56,070
56,169
56,275
65,727
73,798
74,150
74,628
74,926
107,579
107,940
108,224
108,660
108,986
163,078
163,901
164,828
165,395
166,156
167,011
167,899
168,242
169,272
173,149
190,469
191,373
191,889
196,067
211,187
211,590
212,058
212,977
212,843
213,239
213,450
213,662
19,581
20,556
21,840
34,926
35,887
41,161
41,455
50,318
50,628
63,709
63,962
66,429
81,307
97,640
98,441
120,515
121,052
121,545
122,509
124,710
125,665
144,148
145,280
162,772
164,219
164,209
221,594
222,895
224,418
224,418222,895221,594164,209164,219162,772145,280144,148125,665124,710122,509121,545121,052120,51598,44197,64081,30766,42963,96263,70950,62850,31841,45541,16135,88734,92621,84020,55619,581213,662213,450213,239212,843212,977212,058211,590211,187196,067191,889191,373190,469173,149169,272168,242167,899167,011166,156165,395164,828163,901163,078108,986108,660108,224107,940107,57974,92674,62874,15073,79865,72756,27556,16956,07055,9200157,015156,704,899000011007,499103,9170386,167,53700000056,0620-143,8683,7313,765-193,2513,204-350-554-80100000-10000-100-10000-10010035,10031,00030,70090000500000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.